Prognostic Value of Minimal Residual Disease and Polyclonal Plasma Cells in Myeloma Patients Achieving a Complete Response to Therapy.
Marcella A. Tschautscher,Dragan Jevremovic,Vincent Rajkumar,Angela Dispenzieri,Martha Q. Lacy,Morie A. Gertz,Francis K. Buadi,David Dingli,Yi L. Hwa,Amie L. Fonder,Miriam A. Hobbs,Suzanne R. Hayman,Steven R. Zeldenrust,John A. Lust,Stephen J. Russell,Nelson Leung,Prashant Kapoor,Ronald S. Go,Yi Lin,Wilson I. Gonsalves,Taxiarchis Kourelis,Rahma Warsame,Robert A. Kyle,Shaji K. Kumar American Journal of Hematology(2019)
关键词
Minimal Residual Disease,International Myeloma Working Group
AI 理解论文
溯源树
样例
